NUCLEAR(cid:3)ENERGY(cid:3)AND(cid:3)SAFETY
NEUTRON SOURCE FOF NEUTRON CAPTURE THERAPY
OF CANCER TISSUES AT KYIV RESEARCH REACTOR (KRR)
Description
Neutron Capture Therapy (NCT) is a promising form of
radiation therapy characterized by two interrelated features:
(1) the infusion or delivery of a capture compound which
preferentially concentrates in the tumor, followed by (2)
the irradiation of the tumor site with neutrons. Inasmuch
as the boron isotope 5B10 is often used as a neutron capture
agent in compounds, this form of therapy is thus termed
Boron Neutron Capture Therapy (BNCT).
The large thermal neutron capture cross section of
5B10 greatly increases the probability of the resulting 5B11
nucleus to split into He and Li. As the ionization potential
of He and Li ions is high as they slow down in the biologi$
cal material along relatively short distances, the affected
cells enriched by boron are destroyed while normal, heal$
thy cells are damaged to a much lesser extent. However, as
the penetrating capability of thermal neutrons is low, to
reach cancerous tumor cells localized at depths of several
centimeters, epithermal neutrons are more suitable to the
task. Such epithermal neutrons have a lower neutron cap$
ture rate in hydrogen, which results in a lower skin dose
burden while the moderation of epithermal neutrons with$
in the head would give rise to a thermal neutron peak at
the cancerous tumor site. The most suitable neutrons for
BNCT are those with energies in the range of 1 eV to
10 keV because their KERMA factor (and hence direct tis$
sue damage) is less than for thermal or fast neutrons.
Such epithermal neutron beams may be provided by
nuclear research reactors. The concept behind providing
such a source the a modification of the reactor such that
the emergent beam is slowed to the epithermal range. Such
modifications of research reactors are usually relatively
straightforward and not cost prohibitive – especially when
compared to constructing new reactors dedicated to
BNCT. Of course, any modification to a reactor should be
justified with careful design work taking into account all
specifics of a given specific reactor system.
Innovative Aspect and Main Advantages:
–
Existing nuclear research reactors may be readily
modified to provide the proposed epithermal neutron
beam$precluding any need to design and construct a
dedicated reactor;
– Uses a Ni$60 neutron filter for essential improvement
in therapeutic source parameters;
– Destroy tumors by avoiding highly traumatic surgi$
cal techniques;
– High radiation doses are applied directly to malignant
cells while the impact on healthy cells is minimized.
52
Fig. 1. KRR Thermal Column (dimensions in cm):
I – TC (untill reconstruction): A – the first block, B – the second
block. 1 – water, 2 – core, 3 – concrete, 4 – paraffin, 5 – berylM
lium reflector, 6 – graphite. D1, D2, D3 – detector positions in
the MCNP calculations.
II – Geometry for MCNP calculations (vertical cross section
through the core center): 1 – water, 2 – core, 3 – beryllium
reflector (source), 4 – moderator, 5 – reflector (natural nickel),
6 – air, 7 – borated polyethylene, 8 – natural nickel layer.
Areas of Applications:
–
–
Cancer treatment, in particular of brain tumors,
Veterinary medicine.
Stage of Development:
We have demonstrated analytically that an epithermal
neutron source meeting the requirements of BNCT may be
constructed at the nuclear research reactor in Kyiv. The
modification to the reactor may be achieved by altering the
design of the thermal column and replacing the Beryllium
reflector with one based on Aluminum.
Contact Details:
Olena Gritzay, Ph. D.
Institute for Nuclear Research National Academy of
Sciences of Ukraine
Neutron Physics Department
Prospect Nauky, 47, Kyiv 03680, UKRAINE
phone: (380$44) 525$3987; fax: (380$44) 525$4463
EMmail: ogritzay@kinr.kiev.ua
SCIENCE AND INNOVATION. â„– 4, 2006
For more information or to license this innovation:
- Log In
to view the innovation's details
- Sign Up
with discount code "ECOS"